JP2022550828A5 - - Google Patents
Info
- Publication number
- JP2022550828A5 JP2022550828A5 JP2022520291A JP2022520291A JP2022550828A5 JP 2022550828 A5 JP2022550828 A5 JP 2022550828A5 JP 2022520291 A JP2022520291 A JP 2022520291A JP 2022520291 A JP2022520291 A JP 2022520291A JP 2022550828 A5 JP2022550828 A5 JP 2022550828A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- cabotegravir
- administered
- once
- intramuscular injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962908995P | 2019-10-01 | 2019-10-01 | |
| US201962908882P | 2019-10-01 | 2019-10-01 | |
| US62/908,882 | 2019-10-01 | ||
| US62/908,995 | 2019-10-01 | ||
| US202063037782P | 2020-06-11 | 2020-06-11 | |
| US63/037,782 | 2020-06-11 | ||
| US202063052214P | 2020-07-15 | 2020-07-15 | |
| US63/052,214 | 2020-07-15 | ||
| PCT/IB2020/059185 WO2021064618A1 (en) | 2019-10-01 | 2020-10-01 | Method for treating hiv with cabotegravir and rilpivirine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022550828A JP2022550828A (ja) | 2022-12-05 |
| JP2022550828A5 true JP2022550828A5 (enExample) | 2023-10-12 |
| JP7791083B2 JP7791083B2 (ja) | 2025-12-23 |
Family
ID=72826936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520291A Active JP7791083B2 (ja) | 2019-10-01 | 2020-10-01 | カボテグラビルおよびリルピビリンでｈｉｖを治療するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20220347174A1 (enExample) |
| EP (1) | EP4037661A1 (enExample) |
| JP (1) | JP7791083B2 (enExample) |
| KR (1) | KR20220074880A (enExample) |
| CN (2) | CN114502166A (enExample) |
| AU (1) | AU2020358156B2 (enExample) |
| CA (1) | CA3155587A1 (enExample) |
| CL (1) | CL2022000790A1 (enExample) |
| IL (1) | IL290716A (enExample) |
| MX (1) | MX2022003945A (enExample) |
| WO (1) | WO2021064618A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3103522C (en) | 2018-07-16 | 2023-11-21 | Gilead Sciences, Inc. | Capsid inhibitors for the treatment of hiv |
| WO2023222755A1 (en) * | 2022-05-17 | 2023-11-23 | Janssen Sciences Ireland Unlimited Company | Treatment or prevention of hiv infection |
| TW202408526A (zh) * | 2022-05-17 | 2024-03-01 | 愛爾蘭商健生科學愛爾蘭無限公司 | 治療或預防hiv感染(一) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
| US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
| US6319946B1 (en) | 1999-02-12 | 2001-11-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of aspartyl protease |
| PT3366278T (pt) | 2006-06-23 | 2024-10-21 | Janssen Sciences Ireland Unlimited Co | Suspensões aquosas de tmc278 |
| KR101811314B1 (ko) * | 2009-09-22 | 2017-12-26 | 얀센 알 앤드 디 아일랜드 | Ｈｉｖ 감염의 치료 및 예방 |
| EP3351249A1 (en) | 2010-01-27 | 2018-07-25 | VIIV Healthcare Company | Antiviral therapy |
| CN104902905A (zh) | 2012-12-14 | 2015-09-09 | 葛兰素史克有限责任公司 | 药物组合物 |
| US20160067255A1 (en) | 2014-09-04 | 2016-03-10 | Gilead Sciences, Inc. | Methods of treating or preventing hiv in patients using a combination of tenofovir alafenamide and dolutegravir |
| EA201790495A1 (ru) | 2014-09-26 | 2017-09-29 | Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед | Фармацевтические композиции длительного действия |
| WO2019016732A1 (en) * | 2017-07-21 | 2019-01-24 | Viiv Healthcare Company | REGIMES FOR THE TREATMENT OF HIV AND AIDS INFECTIONS |
| CN109568328A (zh) * | 2017-09-29 | 2019-04-05 | 重庆药友制药有限责任公司 | 一种用于预防和治疗hiv感染的药物组合物 |
| EP3986561B1 (en) * | 2019-06-19 | 2024-02-14 | VIIV Healthcare UK (No.5) Limited | Pyrido[2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication |
-
2020
- 2020-10-01 AU AU2020358156A patent/AU2020358156B2/en active Active
- 2020-10-01 KR KR1020227010390A patent/KR20220074880A/ko not_active Ceased
- 2020-10-01 US US17/763,076 patent/US20220347174A1/en not_active Abandoned
- 2020-10-01 EP EP20789687.9A patent/EP4037661A1/en active Pending
- 2020-10-01 CN CN202080069721.1A patent/CN114502166A/zh active Pending
- 2020-10-01 JP JP2022520291A patent/JP7791083B2/ja active Active
- 2020-10-01 WO PCT/IB2020/059185 patent/WO2021064618A1/en not_active Ceased
- 2020-10-01 CN CN202410349180.8A patent/CN118416069A/zh active Pending
- 2020-10-01 MX MX2022003945A patent/MX2022003945A/es unknown
- 2020-10-01 CA CA3155587A patent/CA3155587A1/en active Pending
-
2022
- 2022-02-17 IL IL290716A patent/IL290716A/en unknown
- 2022-03-30 CL CL2022000790A patent/CL2022000790A1/es unknown
-
2025
- 2025-06-04 US US19/227,609 patent/US12636286B2/en active Active
- 2025-06-04 US US19/227,593 patent/US12636285B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541432A5 (enExample) | ||
| JP2018184417A5 (enExample) | ||
| JP2025020134A5 (enExample) | ||
| JP2015187125A5 (enExample) | ||
| JP2022062170A5 (enExample) | ||
| JP2016185995A5 (enExample) | ||
| JP2022527398A5 (enExample) | ||
| RU2010133489A (ru) | Применение ингибиторов гамма-секретазы для лечения рака | |
| JP2017160178A5 (enExample) | ||
| JP2022523726A5 (enExample) | ||
| JP2018507243A5 (enExample) | ||
| JP2018506550A5 (enExample) | ||
| FI3493812T3 (fi) | Imetelstaatin ja venetoklaksin yhdistelmiä akuutin myelooisen leukemian hoitoa varten | |
| JP2021509395A5 (enExample) | ||
| JP2022508513A5 (enExample) | ||
| JP2022531251A5 (enExample) | ||
| JP2024517085A5 (enExample) | ||
| JP2022551691A5 (enExample) | ||
| JP2019534251A5 (enExample) | ||
| JP2025148449A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| JP2021004249A5 (enExample) | ||
| JP2025508098A5 (enExample) | ||
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. | |
| JP2023531090A5 (enExample) |